M Arbyn

Summary

Affiliation: Erasmus University
Country: The Netherlands

Publications

  1. ncbi request reprint Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round
    M E van den Akker-van Marle
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Int J Cancer 73:464-9. 1997
  2. pmc Low risk of cervical cancer during a long period after negative screening in the Netherlands
    M E van den Akker-van Marle
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Br J Cancer 88:1054-7. 2003
  3. ncbi request reprint Cost-effectiveness of cervical cancer screening: comparison of screening policies
    M Elske van den Akker-van Marle
    Department of Public Health, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 94:193-204. 2002
  4. ncbi request reprint Cervical cancer screening in the Netherlands
    M van Ballegooijen
    Erasmus Universiteit Rotterdam, Faculty of Medicine and Health Sciences, Department of Public Health, PO Box 1738, 3000 DR, Rotterdam, The Netherlands
    Eur J Cancer 36:2244-6. 2000
  5. ncbi request reprint Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness
    M van Ballegooijen
    Department of Public Health, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, PO Box 1738, 3000 DR, Rotterdam, The Netherlands
    Eur J Cancer 36:2177-88. 2000
  6. ncbi request reprint Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature
    M Kyrgiou
    Department of Obstetrics and Gynaecology, Victoria Hospital, Blackpool FY3 8NR, UK
    Cancer Treat Rev 33:514-20. 2007
  7. ncbi request reprint European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology
    A Herbert
    Guy s and St Thomas Hospital NHS Foundation Trust, London, UK
    Cytopathology 18:213-9. 2007
  8. ncbi request reprint European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology
    M Arbyn
    Scientific Institute of Public Health, Brussels, Belgium, and European Cancer Network, IARC, Lyon, France
    Cytopathology 18:133-9. 2007
  9. pmc Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination
    J Dillner
    WHO Global Reference Laboratory for HPV Diagnosis and Control, Department of Clinical Microbiology, University Hospital, SE 20502 Malmo, Sweden
    Clin Exp Immunol 148:199-207. 2007
  10. ncbi request reprint European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories
    H G Wiener
    Institute of Clinical Pathology, University Vienna, Austria
    Cytopathology 18:67-78. 2007

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round
    M E van den Akker-van Marle
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Int J Cancer 73:464-9. 1997
    ..Interval cancer rates, results of the subsequent round and size distributions are also crucial indicators of the quality of the screening programme and should be analysed in their specific context...
  2. pmc Low risk of cervical cancer during a long period after negative screening in the Netherlands
    M E van den Akker-van Marle
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Br J Cancer 88:1054-7. 2003
    ..This applies also to the IARC multicountry study, and may have caused too optimistic expectations about the effectiveness of cervical cancer screening...
  3. ncbi request reprint Cost-effectiveness of cervical cancer screening: comparison of screening policies
    M Elske van den Akker-van Marle
    Department of Public Health, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 94:193-204. 2002
    ..e., Pap smears). We compared the efficiency of cervical cancer-screening programs by performing a cost-effectiveness analysis of cervical cancer-screening policies from high-income countries...
  4. ncbi request reprint Cervical cancer screening in the Netherlands
    M van Ballegooijen
    Erasmus Universiteit Rotterdam, Faculty of Medicine and Health Sciences, Department of Public Health, PO Box 1738, 3000 DR, Rotterdam, The Netherlands
    Eur J Cancer 36:2244-6. 2000
    ..At the moment short-term results of implementation of the new screening programme are becoming available. It will take many more years before long-term effects of the new programme will emerge...
  5. ncbi request reprint Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness
    M van Ballegooijen
    Department of Public Health, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, PO Box 1738, 3000 DR, Rotterdam, The Netherlands
    Eur J Cancer 36:2177-88. 2000
    ..The main, and to some extent, unsolvable problem for further improvement of the analysis is the lack of reliable country-specific estimates for the background risk of cervical cancer in women eligible for screening in the near future...
  6. ncbi request reprint Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature
    M Kyrgiou
    Department of Obstetrics and Gynaecology, Victoria Hospital, Blackpool FY3 8NR, UK
    Cancer Treat Rev 33:514-20. 2007
    ..However, protracted attendance for cytological follow-up decreases with time and might put some women at risk of developing invasive disease. The aim of this review was to assess management options for women with minor cervical disease...
  7. ncbi request reprint European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology
    A Herbert
    Guy s and St Thomas Hospital NHS Foundation Trust, London, UK
    Cytopathology 18:213-9. 2007
    ..These guidelines should allow European countries to adapt their terminology in such a way as to make their screening programmes comparable with each other as well as with programmes elsewhere in the world...
  8. ncbi request reprint European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology
    M Arbyn
    Scientific Institute of Public Health, Brussels, Belgium, and European Cancer Network, IARC, Lyon, France
    Cytopathology 18:133-9. 2007
    ..Subsequently, the slide or vial and the completed request form are sent to the laboratory for cytological interpretation...
  9. pmc Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination
    J Dillner
    WHO Global Reference Laboratory for HPV Diagnosis and Control, Department of Clinical Microbiology, University Hospital, SE 20502 Malmo, Sweden
    Clin Exp Immunol 148:199-207. 2007
    ..Internationally standardized monitoring and evaluation of prophylactic HPV vaccination programmes will be essential for arriving at the most (cost-)effective strategies for cancer control...
  10. ncbi request reprint European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories
    H G Wiener
    Institute of Clinical Pathology, University Vienna, Austria
    Cytopathology 18:67-78. 2007
    ..The guidelines are extensively referenced and as far as possible the recommendations are evidence-based...
  11. ncbi request reprint Ovarian cancer screening
    M Kyrgiou
    Department of Obstetrics and Gynaecology, Hammersmith Hospital, Queen Charlotte s and Chelsea Hospital, London, W12 OHS
    Anticancer Res 26:4793-801. 2006
    ..This review presents the current knowledge on ovarian cancer screening (OCS) together with a cumulative evaluation of the efficacy across diverse screening approaches based on up-to-date results...
  12. ncbi request reprint Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation
    J Verguts
    Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, Catholic University Leuven, Leuven, Belgium
    BJOG 113:1303-7. 2006
    ....
  13. pmc Cervical cancer screening programmes and policies in 18 European countries
    A Anttila
    The Finnish Cancer Registry, Helsinki, Finland
    Br J Cancer 91:935-41. 2004
    ..Our survey indicated that the recommendations as currently given are met in only few European countries. Health authorities need to consider stronger measures and incentives than those laid out in the current set of recommendations...
  14. ncbi request reprint Rapid pre-screening of Pap smears in quality control: an Italian experience
    A Placidi
    Cytopathology 15:121-3. 2004
  15. pmc Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women
    C E Depuydt
    Laboratory for Clinical Pathology Labo RIATOL, Antwerp, Belgium
    Br J Cancer 88:560-6. 2003
    ..7%). In Flanders, HSIL was most often associated with HPV types 16, 33, 35, 31, 18 and 51. Using thin-layer liquid-based cytology and PCR to detect HPV, it is feasible to screen large numbers of women...
  16. doi request reprint Cervical cytology biobanking: quality of DNA from archival cervical Pap-stained smears
    G A V Boulet
    Applied Molecular Biology Research AMBIOR, Laboratory of Cell Biology and Histology, University of Antwerp, Antwerp, Belgium
    J Clin Pathol 61:637-41. 2008
    ..This study evaluates three commercial isolation methods and one digestion procedure for their ability to obtain DNA suitable for PCR from fixed and stained Pap smears...